Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

ABT MDT SYK ISRG CNY Bitcoins Macroaxis 20 Investor Favorites Money Funds 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Processing. Please wait...

Nxstage Short Ratio

 
 Companies |  Insiders  | Dashboard  
     
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Nxstage

Short Ratio

=

Short Interest

Average Trading Volume

=
10.90 times
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare Nxstage to competition

Nxstage Short Ratio Assessment

Based on latest financial disclosure Nxstage Medical Inc has Short Ratio of 10.9 times. This is 215.94% higher than that of Healthcare sector, and 258.55% higher than that of Medical Appliances and Equipment industry, The Short Ratio for all stocks is 603.23% lower than the firm.

Filter other Stocks by Short Ratio

Select Short Ratio Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Nxstage is currently under evaluation in short ratio category among related companies.
Follow Nxstage Short Ratio with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Nxstage to your reader
 
    
NXTM United States Nasdaq
Nxstage Medical Inc
Benchmark S&P 500
Currency: USD - US Dollar
Traded on NASDAQ
    
    

Other Nxstage Fundamentals

Return On Equity(8.61) %
Return On Asset(2.48) %
Profit Margin(6.08) %
Operating Margin(4.89) %
Current Valuation680.96 M
Shares Outstanding59.74 M
Shares Owned by Insiders8.45 %
Shares Owned by Institutions84.60 %
Number of Shares Shorted3 M
Price to Book4.10 times
Price to Sales3.27 times
Revenue246.82 M
Gross Profit92.81 M
EBITDA(1.55 M)
Net Income(15 M)
Cash and Equivalents99.8 M
Cash per Share1.67 times
Total Debt11.56 M
Debt to Equity0.06 times
Current Ratio3.87 times
Book Value Per Share3.30 times
Cash Flow from Operations2.44 M
Short Ratio10.90 times
One Year High17.15
One Year Low10.15
Earnings Per Share(0.26) times
Price to Earnings To Growth(2.46) times
Number of Employees2.7 K
Beta0.64
Market Capitalization820.77 M
Total Asset312.2 M
Retained Earnings(349.98 M)
Working Capital121.33 M
Current Asset163.65 M
Current Liabilities42.32 M
Z Score41.2
Probability Of Bankruptcy1.00 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium